FDA 483 OBSERVATION · #89 OF 1,945 MOST-CITED
Prevention of contamination
FDA cited this observation 314 times across 255 firms in recent inspections. Below: how it breaks down by program area and fiscal year, and real examples of how FDA worded it on Form FDA 483.
What this observation means, and how to comply
SPEQ's practitioner reading of this finding. The regulatory basis is a cited fact; the interpretation, compliance steps, and root causes are SPEQ synthesis — not an FDA classification of the citation.
Manufacturing, processing, packing, and holding operations were not conducted with adequate controls to prevent food from becoming contaminated. This is the broad processes-and-controls requirement covering cross-contamination, foreign material, and microbial ingress during actual operations.
Why FDA writes it — Contamination introduced during processing reaches product that ships to consumers; FDA cites this when the operation lacks the routine physical, chemical, and microbial safeguards — segregation, protection, and handling controls — that keep raw materials, in-process food, and finished product safe.
- Define and follow written controls that segregate raw from finished product and prevent cross-contact during handling.
- Protect food, containers, and food-contact surfaces from contamination by drips, condensate, foreign material, and personnel.
- Control the parameters (time, temperature, pH, water activity) that keep microbial growth and contamination in check during operations.
- Monitor these controls, record the results, and take corrective action when a control is not met.
- Processing controls exist on paper but are not embedded in line practice, so operators improvise when conditions change.
- The operation was scaled up or a new product added without reassessing where contamination could enter the process.
How to close this finding — and stop it recurring
What this observation is associated with
Firms cited for this observation also appear in FDA compliance actions — warning letters, injunctions, or seizures — at 0.2× the rate of the average FDA-cited firm (1.6% vs 7.8%), across 255 FEI-matched firms.
This is an association, not causation, and reflects co-occurrence in FDA's records — not a claim that the observation caused or preceded the action.
How FDA worded it — real examples
Failure to maintain and operate servicing area piping systems and hydrants in such a manner as to prevent contamination of drinking and culinary water.
Failure to maintain servicing area in such a manner as to prevent contamination of drinking water.
Failure to maintain and operate servicing area piping systems, hydrants and hoses in such a manner as to prevent contamination of drinking and culinary water.
Failure to design, maintain and operate servicing area piping systems in such a manner as to prevent contamination of drinking water.
Failure to maintain and operate servicing area piping systems, hydrants and hoses in such a manner as to prevent contamination of drinking and culinary water.
Failure to maintain servicing area in such a manner as to prevent contamination of drinking water.
Related SPEQ references
Where to read the requirements behind this observation area on SPEQ. These are SPEQ's topic and audience pages — not an FDA classification of the citation.
Examples are a representative sample of FDA's published inspection observations. Open the 483 observation explorer →